Commandeur J N, Stijntjes G J, Wijngaard J, Vermeulen N P
Department of Pharmacochemistry, Free University, Amsterdam, The Netherlands.
Biochem Pharmacol. 1991 Jun 21;42(1):31-8. doi: 10.1016/0006-2952(91)90677-w.
The relationship between the relative nephrotoxicity of the mercapturic acids (NAc) of the fluorinated ethylenes tetrafluoroethylene (TFE), chlorotrifluoroethylene (CTFE), 1,1-dichloro-2,2-difluoroethylene (DCDFE) and 1,1-dibromo-2,2-difluoroethylene (DBDFE), and the biotransformation by activating (N-deacetylase and beta-lyase) and inactivating (N-acetyltransferase) enzymes was studied in the rat. After intraperitoneal (i.p.) administration of 50 mumol/kg of N-(trideuteroacetyl)-labeled mercapturic acids of DCDFE and DBDFE to rats, significant amounts of the dose were excreted unchanged: with DCDFE-NAc, 17% of the dose, and DBDFE-NAc, 31% of the dose. In contrast, the corresponding deuterium-labeled mercapturic acids of TFE and CTFE were excreted unchanged at less than 1% of the dose. With DCDFE-NAc and DBDFE-NAc, also high amounts of unlabeled mercapturic acids were excreted, respectively 48% and 28% of the dose, indicating extensive N-deacetylation followed by reacetylation in vivo. Only small amounts (less than 2%) of unlabeled mercapturic acids were excreted with TFE-NAc and CTFE-NAc. After administration of the cysteine S-conjugates DCDFE-Cys and DBDFE-Cys to rats, high amounts of the corresponding mercapturic acids were detected in urine, respectively 57% and 45% of the dose. After administration of TFE-Cys and CTFE-Cys, however, only small amounts were excreted as the corresponding mercapturic acid, approximately 4% of the dose. The strongly different amounts of mercapturic acids in urine may be attributed to the strong differences in N-deacetylation activities which were found in rat renal fractions. The threshold dose of the mercapturic acids to cause nephrotoxicity in male Wistar rats increased in the order: CTFE-NAc (25 mumol/kg) less than TFE-NAc (50 mumol/kg) less than DCDFE-NAc (75 mumol/kg) less than DBDFE-NAc (100 mumol/kg). A higher ratio of N-deacetylation and N-acetylation activities, resulting in a higher availability of cysteine S-conjugate, in addition to a higher specific activity of cysteine S-conjugate beta-lyase, probably explains the higher nephrotoxicity of TFE-NAc and CTFE-NAc when compared to DCDFE-NAc and DBDFE-NAc. The much lower activities of N-deacetylation and beta-lyase which are observed in hepatic fractions may explain the lack of hepatotoxicity of the mercapturic acids studied.
研究了大鼠体内四氟乙烯(TFE)、三氟氯乙烯(CTFE)、1,1-二氯-2,2-二氟乙烯(DCDFE)和1,1-二溴-2,2-二氟乙烯(DBDFE)的硫醚氨酸(NAc)的相对肾毒性与通过激活酶(N-脱乙酰酶和β-裂解酶)和失活酶(N-乙酰转移酶)进行生物转化之间的关系。给大鼠腹腔注射50 μmol/kg的DCDFE和DBDFE的N-(三氘代乙酰基)标记硫醚氨酸后,大量剂量未发生变化就被排出:DCDFE-NAc为剂量的17%,DBDFE-NAc为剂量的31%。相比之下,TFE和CTFE相应的氘代标记硫醚氨酸未发生变化排出的量不到剂量的1%。对于DCDFE-NAc和DBDFE-NAc,也有大量未标记的硫醚氨酸排出,分别为剂量的48%和28%,表明在体内发生了广泛的N-脱乙酰化,随后又重新乙酰化。TFE-NAc和CTFE-NAc排出的未标记硫醚氨酸量很少(不到2%)。给大鼠注射半胱氨酸S-共轭物DCDFE-Cys和DBDFE-Cys后,尿液中检测到大量相应的硫醚氨酸,分别为剂量的57%和45%。然而,注射TFE-Cys和CTFE-Cys后,只有少量以相应的硫醚氨酸形式排出,约为剂量的4%。尿液中硫醚氨酸量的显著差异可能归因于在大鼠肾部分中发现的N-脱乙酰化活性的强烈差异。雄性Wistar大鼠中引起肾毒性的硫醚氨酸阈值剂量按以下顺序增加:CTFE-NAc(25 μmol/kg)<TFE-NAc(50 μmol/kg)<DCDFE-NAc(75 μmol/kg)<DBDFE-NAc(100 μmol/kg)。与DCDFE-NAc和DBDFE-NAc相比,TFE-NAc和CTFE-NAc的肾毒性更高,可能是由于N-脱乙酰化和N-乙酰化活性的比例更高,导致半胱氨酸S-共轭物的可用性更高,此外半胱氨酸S-共轭物β-裂解酶的比活性也更高。在肝部分中观察到的N-脱乙酰化和β-裂解酶活性低得多,这可能解释了所研究的硫醚氨酸缺乏肝毒性的原因。